Results 51 to 60 of about 22,158 (212)

Positive modulation of glucagon‐like peptide 1 (GLP‐1) receptor by endogenous haemorphins with implications in glucose metabolism and diabetes

open access: yesBritish Journal of Pharmacology, EarlyView.
Haemorphins act on GLP‐1 receptor (GLP‐1R) activity and signalling in a positive allosteric manner. This leads to potentiated GLP‐1‐mediated activity and signalling, as well as insulin synthesis, which may have implications for glucose metabolism and, thereby, diabetes and obesity. (The graph was created in BioRender.com).
Farheen Badrealam Khan   +13 more
wiley   +1 more source

Cortisol Response to Hypoglycemia in Insulinoma: Clinical and Biochemical Correlates

open access: yesEndocrinology Research and Practice
Objective: Insulinoma is the most frequent cause of endogenous hyperinsulinemic hypoglycemia. Recurrent hypoglycemia may impair the hypothalamic–pituitary–adrenal axis.
Yusuf Öztürk, Mustafa Kulaksızoğlu
doaj   +1 more source

Pancreatic insulinoma causing hypoglycemic episodes

open access: yesJournal of Pediatric Surgery Case Reports, 2020
Background: Insulinoma typically has non-specific neuroglycopenic symptoms. It is a neuroendocrine tumor of the pancreas, and leads to recurring hypoglycemic attacks stemming from insulin hypersecretion.
Moaffaq Mahdi   +3 more
doaj   +1 more source

Clinicopathological and immunohistochemical features of insulinoma in an adult mixed breed dog

open access: yesBrazilian Journal of Veterinary Pathology, 2023
Canine insulinoma is a common non-specific neoplasm with high metastasizing ability. Its epidemiology, diagnosis, and treatment are well described. However, its long-term prognosis is considered poor.
Isabeli Joaquim Contel   +8 more
doaj   +1 more source

Endoscopic Ultrasound‐Guided Ethanol Ablation for Benign Insulinoma: A Single‐Centre Experience and Literature Review

open access: yesClinical Endocrinology, EarlyView.
ABSTRACT Objectives Insulinoma is a predominantly benign pancreatic neuroendocrine tumour that is traditionally managed surgically. However, surgical invasiveness and anaesthesia‐related risks limit its applicability in selected patients. Endoscopic ultrasound (EUS)‐guided ethanol ablation has emerged as a minimally invasive alternative.
Yuchao Wu   +15 more
wiley   +1 more source

Pancreatic β‐cell mitogenic regeneration in type 1 diabetes: A preclinical review

open access: yesDiabetic Medicine, EarlyView.
Abstract Type 1 diabetes (T1D) is caused by autoimmune destruction of insulin‐producing pancreatic β‐cells, resulting in hyperglycaemia. The first‐line treatment for symptomatic T1D is exogenous insulin replacement to maintain glycaemic control.
James Cantley   +3 more
wiley   +1 more source

Progression to type 1 diabetes across the autoimmunity and glycaemia continuum: Insights from real‐world paediatric and adult cohorts

open access: yesDiabetic Medicine, EarlyView.
Abstract Background Type 1 diabetes (T1D) follows a staged autoimmune natural history, yet most evidence describing progression derives from highly selected, genetically at‐risk cohorts. Methods Using the TriNetX Network, we identified eight cohorts of autoantibody‐positive individuals without prior T1D. Four cohorts had preserved glycaemia (HbA1c ≤5.6%
Matthew Anson   +7 more
wiley   +1 more source

Immune‐competent organ‐on‐chip methodologies to study type 1 diabetes

open access: yesDiabetic Medicine, EarlyView.
Abstract Aims Type 1 diabetes (T1D) is a self‐driving autoimmune condition leading to the death of insulin‐producing β‐cells of the pancreas. β‐cell‐reactive immune cell extravasation into the intra‐islet space is fuelled by a cycle of inflammation including immune, vascular and endocrine dysfunction. Since clinical pancreatic biopsy is contraindicated,
Maja Witowska   +4 more
wiley   +1 more source

Insulinoma apresentando-se como crise convulsiva: relato de caso Insulinoma presenting as seizure: case report

open access: yesArquivos de Neuro-Psiquiatria, 2005
O insulinoma é doença rara que cursa com sintomas episódicos neuroglicopênicos e/ou adrenérgicos. Descrevemos o caso de uma paciente de 36 anos, que estava sendo tratada por crises convulsivas parciais complexas há 4 anos sem melhora do quadro ...
Carlos Alexandre Twardowschy   +3 more
doaj   +1 more source

Hipoglucemia e insulinoma

open access: yesRevista Mexicana de Endocrinología, Metabolismo y Nutrición, 2022
La hipoglucemia persistente causada por un insulinoma es una patología poco frecuente que requiere un diagnóstico bioquímico y localización regional del tumor ante la sospecha para un tratamiento adecuado.
Isabel Pulgar-Sedó   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy